Oxycodone/paracetamol controlled release - Mallinckrodt

Alternative Names: Acetaminophen/oxycodone hydrochloride; COV-795; MNK-795; Oxycodone hydrochloride/acetaminophen; Xartemis XR

Latest Information Update: 29 Nov 2016

Price : ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator Mallinckrodt Inc.
Class Acetanilides; Antipyretics; Antirheumatics; Morphine derivatives; Non-opioid analgesics; Opioid analgesics
Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists; Prostaglandin receptor antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Acute pain

Most Recent Events

22 Nov 2016 Phase-I clinical trials in Acute pain (In volunteers) in USA (PO) (NCT02966860)
15 Nov 2016 Mallinckrodt completes the phase I trial in Healthy volunteers in USA (NCT02966860)
17 Apr 2014 Launched for Acute pain in USA (PO) - First global launch

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.